Sign in
4

Changes in Ownership

MoonLake Immunotherapeutics Filed Acc 0001213900-25-019672

Chief Financial Officer acquired 95,763 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Bodenstedt Matthias Chief Financial Officer 2025-02-27 Grant or award +95,763 616,666 D
Loading xslF345X05/ownership.xml…